MiR-320e is a novel prognostic biomarker in colorectal cancer - Perez-Carbonell, L; Sinicrope, F A; Alberts, S R; Oberg, A L; Balaguer, F; Castells, A; Boland, C R; Goel, A (British journal of cancer, 2015)
Keywords: 631/337/384/331; 692/420/2489/68; 692/699/67/1504/1885; 692/699/67/1857; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols - therapeutic use; Biomarkers; Biomarkers, Tumor - blood; Biomedical and Life Sciences; Biomedicine; Cancer Research; Cancer therapies; Chemotherapy; Clinical trials; Cohort Studies; Colorectal cancer; Colorectal Neoplasms - blood; Colorectal Neoplasms - drug therapy; Colorectal Neoplasms - physiopathology; Drug Resistance; Epidemiology; Female; Fluorouracil - therapeutic use; Gastroenterology; Genomes; Humans; Leucovorin - therapeutic use; Male; Medical prognosis; Medical research; Metastasis; MicroRNAs; MicroRNAs - blood; Middle Aged; Molecular Medicine; molecular-diagnostics; Oncology; Organoplatinum Compounds - therapeutic use; Patients; Prognosis; United States--US; microRNAs; 5-fluorouracil; expression; colorectal cancer; biomarker; prognosis